about
At the end of the 70s, a French aesthetic doctor, Dr Michel Tordjman, passionate about cellular biology, put a team of specialists together to assist him in launching an advanced research program on cutaneous ageing.
OBJECTIVE :
To understand the ageing process and to cure it through a global therapy that includes complementary anti-ageing medical techniques to treat efficiently not only wrinkles, but also the lack of firmness and brightness of the skin.
As absolute pioneers in this field, FILORGA Laboratories, use the results of these works to develop in the early 90’s biological products able to fight in situ the whole ageing process :
Anti-ageing mesotherapy (with the famous poly revitalising complex NCTF®), glycolic peels (with GlyKopeel®), and filling injectables (Filorga's complete range of Fillers include XHA³, XHA-Volume and M-HA18).
Renowned by dermatologists, aesthetic doctors and plastic surgeons in over 32 countries, FILORGA Laboratories are recognized as the experts on cutaneous ageing.
In 2006, the new research and production unit of FILORGA Laboratories acquired the ISO13485 seal of approval that certifies that the organisation complies with the standards governing the manufacture of medical devices. More recently OSEO ANVAR also awarded them the "Innovative Business" qualification.
From innovation to innovation, the brand has, throughout the years, become one of medical anti-ageing more undisputed player.